Why Oral Bioavailability Is Lower Even though BPC-157 survives gastric acid better than most peptides, oral administration still subjects it to: First-pass metabolism the liver processes a significant portion before it reaches systemic circulation Variable absorption affected by food, stomach pH, and individual GI function Enzymatic degradation some breakdown still occurs in the intestinal tract The result is that oral BPC-157 delivers a lower and less predictable systemic dose compared to injection
Many people benefit from a single injection, but some may require two or three treatments spaced a few weeks apart depending on the severity of the tendon damage
I had covid in January, Ive been struggling with pain, recurrent symptoms, fatique and headaches
Blagic A, Blagic V, Mirt M, Jelovac N, Dodig G, Gastric pentadecapeptide BPC 157 effective against serotonin syndrome in rats